Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Biohaven Ltd | BHVN | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 38.72 | 04:01:17 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 38.72 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 12.35 - 62.21 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 38.72 | USD |
Biohaven (BHVN) Options Flow Summary
Biohaven Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.16B | 81.58M | - | 0 | -408.17M | -5.00 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Biohaven News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BHVN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 42.90 | 43.31 | 37.61 | 40.05 | 2,242,385 | -4.18 | -9.74% |
| 1 Month | 57.02 | 57.02 | 37.61 | 45.25 | 1,401,522 | -18.30 | -32.09% |
| 3 Months | 44.92 | 62.21 | 37.61 | 50.73 | 1,324,554 | -6.20 | -13.80% |
| 6 Months | 27.47 | 62.21 | 25.97 | 43.81 | 1,227,171 | 11.25 | 40.95% |
| 1 Year | 13.55 | 62.21 | 12.35 | 33.17 | 1,166,188 | 25.17 | 185.76% |
| 3 Years | 74.63 | 152.56 | 7.10 | 64.86 | 1,039,698 | -35.91 | -48.12% |
| 5 Years | 63.07 | 152.56 | 7.10 | 62.35 | 920,574 | -24.35 | -38.61% |
Biohaven Description
| Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. |
